Prudence A. E. Scott

2.7k total citations · 1 hit paper
27 papers, 2.3k citations indexed

About

Prudence A. E. Scott is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Prudence A. E. Scott has authored 27 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Prudence A. E. Scott's work include Angiogenesis and VEGF in Cancer (20 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Lymphatic System and Diseases (4 papers). Prudence A. E. Scott is often cited by papers focused on Angiogenesis and VEGF in Cancer (20 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Lymphatic System and Diseases (4 papers). Prudence A. E. Scott collaborates with scholars based in United Kingdom, New Zealand and India. Prudence A. E. Scott's co-authors include Adrian L. Harris, Roy Bicknell, Stephen B. Fox, Russell Leek, Amir Moghaddam, Margaret J. Currie, Bridget A. Robinson, Karen Smith, S LeJeune and R Whitehouse and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and JNCI Journal of the National Cancer Institute.

In The Last Decade

Prudence A. E. Scott

27 papers receiving 2.3k citations

Hit Papers

Expression of the angiogenic factors vascular endothelial... 1997 2026 2006 2016 1997 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    1997 700 citations Prudence A. E. Scott, Stephen B. Fox et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prudence A. E. Scott United Kingdom 20 1.8k 934 885 305 150 27 2.3k
Paul Meltzer United States 7 1.8k 1.0× 824 0.9× 768 0.9× 235 0.8× 206 1.4× 10 2.4k
Nabendu Pore United States 17 1.4k 0.8× 1.1k 1.1× 614 0.7× 287 0.9× 109 0.7× 26 2.3k
Rachel Tsan United States 23 1.3k 0.8× 514 0.6× 1.3k 1.5× 663 2.2× 116 0.8× 29 2.5k
Oskar W. Rokhlin United States 26 1.4k 0.8× 583 0.6× 557 0.6× 347 1.1× 139 0.9× 49 2.0k
Jürgen Veeck Germany 30 2.3k 1.3× 704 0.8× 677 0.8× 423 1.4× 247 1.6× 45 3.0k
Qunsheng Ji China 25 1.5k 0.8× 560 0.6× 686 0.8× 538 1.8× 113 0.8× 50 2.5k
Douglas S. Micalizzi United States 14 1.6k 0.9× 841 0.9× 1.2k 1.3× 293 1.0× 125 0.8× 25 2.4k
Zhengsheng Wu China 27 1.5k 0.8× 953 1.0× 683 0.8× 185 0.6× 128 0.9× 69 2.3k
Baocun Sun China 38 2.1k 1.2× 1.3k 1.4× 974 1.1× 294 1.0× 80 0.5× 64 2.9k
Ray Somcio United States 17 1.3k 0.7× 671 0.7× 1.0k 1.2× 217 0.7× 70 0.5× 23 2.0k

Countries citing papers authored by Prudence A. E. Scott

Since Specialization
Citations

This map shows the geographic impact of Prudence A. E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence A. E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence A. E. Scott more than expected).

Fields of papers citing papers by Prudence A. E. Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prudence A. E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence A. E. Scott. The network helps show where Prudence A. E. Scott may publish in the future.

Co-authorship network of co-authors of Prudence A. E. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Prudence A. E. Scott. A scholar is included among the top collaborators of Prudence A. E. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prudence A. E. Scott. Prudence A. E. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doig, Kenneth, Andrew Fellowes, Prudence A. E. Scott, & Stephen B. Fox. (2022). Tumour mutational burden: an overview for pathologists. Pathology. 54(3). 249–253. 12 indexed citations
2.
Bolton, Damien, David Clouston, James G. Dowty, et al.. (2022). Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer. Cancers. 14(15). 3623–3623. 1 indexed citations
3.
Currie, Margaret J., Sarah Gunningham, Kevin Turner, et al.. (2002). Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia. The Journal of Pathology. 198(4). 502–510. 70 indexed citations
4.
Gunningham, Sarah, Margaret J. Currie, Cheng Han, et al.. (2001). VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. The Journal of Pathology. 193(3). 325–332. 53 indexed citations
5.
Scott, Prudence A. E., Aksel Lange, & Nicholas J. Kruger. (2000). Photosynthetic carbon metabolism in leaves of transgenic tobacco ( Nicotiana tabacum L.) containing decreased amounts of fructose 2,6-bisphosphate. Planta. 211(6). 864–873. 29 indexed citations
6.
Scott, Prudence A. E., Lucia Morbidelli, S. A. PEAK, et al.. (2000). The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. British Journal of Cancer. 83(1). 63–68. 134 indexed citations
7.
Gunningham, Sarah, Margaret J. Currie, Han Cheng, et al.. (2000). The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.. PubMed. 6(11). 4278–86. 88 indexed citations
8.
Giatromanolaki, Alexandra, Michael I. Koukourakis, S. Kakolyris, et al.. (1998). Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.. PubMed. 4(12). 3017–24. 115 indexed citations
9.
Turley, Helen, et al.. (1998). Expression of VEGF in routinely fixed material using a new monoclonal. The Journal of Pathology. 186(3). 313–318. 71 indexed citations
10.
Scott, Prudence A. E., K Smith, Richard Poulsom, et al.. (1998). Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. British Journal of Cancer. 77(12). 2120–2128. 97 indexed citations
11.
Scott, Prudence A. E., Jonathan Gleadle, Roy Bicknell, & Adrian L. Harris. (1998). Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. International Journal of Cancer. 75(5). 706–712. 55 indexed citations
12.
Zhang, Lyna, Prudence A. E. Scott, Helen Turley, et al.. (1998). Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. The Journal of Pathology. 185(4). 402–408. 64 indexed citations
13.
Turley, Helen, et al.. (1998). Expression of VEGF in routinely fixed material using a new monoclonal. The Journal of Pathology. 186(3). 313–318. 4 indexed citations
14.
Scott, Prudence A. E.. (1997). A reliable external control for ribonuclease protection assays. Nucleic Acids Research. 25(6). 1305–1306. 19 indexed citations
15.
Harris, Adrian L., Huatang Zhang, Amir Moghaddam, et al.. (1996). Breast cancer angiogenesis — new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Research and Treatment. 38(1). 97–108. 47 indexed citations
16.
Craft, Paul, Prudence A. E. Scott, Marina Ziche, et al.. (1995). Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma Cells. JNCI Journal of the National Cancer Institute. 87(3). 213–219. 238 indexed citations
17.
Scott, Prudence A. E. & Adrian L. Harris. (1994). Current approaches to targeting cancer using antiangiogenesis therapies. Cancer Treatment Reviews. 20(4). 393–412. 44 indexed citations
18.
Scott, Prudence A. E. & Roy Bicknell. (1993). The isolation and culture of microvascular endothelium. Journal of Cell Science. 105(2). 269–273. 60 indexed citations
19.
Scott, Prudence A. E. & Gerald A. Maguire. (1990). A kinetic assay for urea in undiluted urine specimens. Clinical Chemistry. 36(10). 1830–1834. 2 indexed citations
20.
Bobik, Alex, et al.. (1988). Relationships Between the Cardiovascular Effects of α-Methyldopa and Its Metabolism in Pontomedullary Noradrenergic Neurons of the Rabbit. Journal of Cardiovascular Pharmacology. 11(5). 529–537. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Meltzer Breakdown of academic impact, for papers by Nabendu Pore Breakdown of academic impact, for papers by Rachel Tsan Breakdown of academic impact, for papers by Oskar W. Rokhlin Breakdown of academic impact, for papers by Jürgen Veeck Breakdown of academic impact, for papers by Qunsheng Ji Breakdown of academic impact, for papers by Douglas S. Micalizzi Breakdown of academic impact, for papers by Zhengsheng Wu Breakdown of academic impact, for papers by Baocun Sun Breakdown of academic impact, for papers by Ray Somcio
Rankless by CCL
2026